Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia

Fig. 4

High expression of A2M in CD9+ AML LSCs. a Venn diagram analysis of RNA-seq results from AML-LSCs (CD9+) and non-LSCs (CD9−) of three AML patients. b Heatmap showing 52 common differentially expressed genes in the three AML patients. c Gene ontology analysis of genes in the heatmap. d The expression levels of 7 genes associated with extracellular matrix organization were detected by RT-PCR. e The expression levels of A2M in CD9+ cells than CD9− cells are detected by Western blotting

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512